SignalPoint Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
SignalPoint Asset Management's ARKG Position: Q1 2024 in Review
SignalPoint Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 6,565 shares — an estimated $215K sold.
SignalPoint Asset Management first reported a position in ARKG in Q3 2020 and held it in 12 quarters. The position peaked at $1.1M in Q1 2021. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.
- SignalPoint Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
- SignalPoint Asset Management sold 6,565 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $215K.
- SignalPoint Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 12 quarters.
- SignalPoint Asset Management's ARK Genomic Revolution ETF position peaked at $1.1M in Q1 2021.
- 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.
Based on SignalPoint Asset Management's 13F filing for Q1 2024, filed 11 Apr 2024.